“SAFETY CONCERNS” HALT ANOTHER COVID DRUG TRIAL

FROM BITCHUTE

“SAFETY CONCERNS” HALT ANOTHER COVID DRUG TRIAL

With media attention focused on the #COVID19 “vaccine unicorn”, several alternative therapeutics currently in trial are getting little attention. Monoclonal antibody cocktails,
touted by President Trump, claim to give Covid patients a boost of synthetic antibodies to help fight against the virus. Sounds great, but is there a catch? Eli Lilly has put their late-stage trial on hold due to a safety concern, leaving the public in the dark as to why.

#CovidTrials #Safety #EliLilly #OnHold #Health #Covid19 #TheHighWire

Orignal Source: https://www.bitchute.com/video/zAkwE3pQYKGr

0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

More from Highwire with Del Bigtree: